Denis Chem Lab Ltd

Denis Chem Lab Ltd announced the reappointment of Dr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026. This decision, made by the Board of Directors based on the Nomination and Remuneration Committee's recommendation, is subject to shareholder approval at the upcoming 45th AGM. Dr. Patel, an industrialist with over four decades of experience in the medical and pharmaceuticals field, holds 2,048,137 equity shares in the company. The company also affirmed that Dr. Patel is not debarred from holding a director's office by any SEBI order.

Denis Chem Lab Ltd announced that its Board of Directors, in a meeting held on July 29, 2026, has fixed Friday, September 18, 2026, as the record date for determining shareholders eligible to receive the final dividend for FY 2025-26, if declared at the upcoming 45th Annual General Meeting (AGM). The AGM is scheduled for Friday, September 25, 2026, at 12:00 p.m. IST, to be conducted via Video Conferencing. The company also approved the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years and the re-appointment of Dr. Himanshu C. Patel as Managing Director for three years, both subject to shareholder approval. Shareholders will have remote e-voting facility from September 22 to September 24, 2026.

Denis Chem Lab Ltd announced the re-appointment of Mr. Himanshu C. Patel as Managing Director for a period of three years, effective August 1, 2026. This decision was made during the Board of Directors' meeting held on July 29, 2026, and is subject to shareholder approval at the upcoming 45th Annual General Meeting (AGM). The AGM is scheduled for September 25, 2026, and will be conducted via Video Conferencing. The Board also fixed September 18, 2026, as the record date for determining shareholders eligible for the final dividend for FY 2025-26, if declared. Additionally, the company appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years.

Denis Chem Lab Ltd announced the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for a five-year term from FY 2026-27 to 2030-31, subject to shareholder approval at the upcoming AGM. The Board also approved the re-appointment of Dr. Himanshu C. Patel as Managing Director for three years from August 1, 2026. The 45th Annual General Meeting is scheduled for September 25, 2026, with September 18, 2026, set as the record date for determining dividend entitlement for FY 2025-26. E-voting facilities will be available.

Denis Chem Lab Ltd announced key dates following its Board Meeting on July 29, 2026. The 45th Annual General Meeting (AGM) is scheduled for September 25, 2026, to be held via Video Conferencing. The record date for determining shareholders eligible for the final dividend for FY 2025-26 has been fixed as September 18, 2026. Shareholders will have the facility for remote e-voting from September 22 to September 24, 2026. Additionally, the Board approved the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years and the re-appointment of Dr. Himanshu C. Patel as Managing Director for three years, subject to shareholder approval.

Denis Chem Lab Ltd announced that its Board of Directors, in a meeting held on July 29, 2026, has decided to convene the 45th Annual General Meeting (AGM) on September 25, 2026. The meeting will be held virtually. The Board has fixed September 18, 2026, as the record date for determining shareholders eligible for a final dividend for FY 2025-26, if declared at the AGM. Shareholders will have the facility for remote e-voting from September 22 to September 24, 2026. Additionally, the Board approved the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors for five years and the re-appointment of Dr. Himanshu C. Patel as Managing Director for three years, subject to shareholder approval.

Denis Chem Lab Ltd's board approved the standalone audited financial statements for the quarter and financial year ended March 31, 2026. They recommended a final dividend of ₹2.50 per equity share of ₹10 each for FY26, subject to shareholder approval. The board appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors and M/s. Kiran J. Mehta & Co. as Cost Auditors for FY 2026-27.

Denis Chem Lab Ltd's board approved the standalone audited financial statements for the year ended March 31, 2026, and recommended a final dividend of ₹2.50 per equity share. They also appointed M/s. Kashyap R. Mehta & Partners as secretarial auditor, filling a vacancy. Additionally, M/s. Kiran J. Mehta & Co. was appointed as cost auditors for FY 2026-27. The decisions were made during the board meeting held on May 30, 2026.

Denis Chem Lab Ltd appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditors due to the resignation of M/s. Nishant Pandya & Associates. The board also approved the standalone audited financial statements for the year ended March 31, 2026, and recommended a final dividend of ₹2.50 per equity share. Additionally, M/s. Kiran J. Mehta & Co. was appointed as Cost Auditors for FY 2026-27.

The Board of Directors of Denis Chem Lab Ltd, in its meeting held on May 30, 2026, recommended a final dividend of ₹2.50 per equity share of ₹10 each (25%) for the financial year 2025-26, subject to shareholder approval. The board also approved the standalone audited financial statements for the quarter and financial year ended March 31, 2026. Additionally, M/s. Kashyap R. Mehta & Partners were appointed as Secretarial Auditors, and M/s. Kiran J. Mehta & Co. were appointed as Cost Auditors for FY 2026-27.